On the occasion of World Cancer Day 2024; focus on hypertension and anti-cancer agents

被引:0
|
作者
Tajdini, Parisa [1 ,2 ]
Foroutan, Majid [3 ,4 ]
机构
[1] Semnan Univ Med Sci, Sch Med, Dept Pediat, Semnan, Iran
[2] Semnan Univ Med Sci, Amir Al Momenin Educ Res & Therapeut Hosp, Clin Res Dev Unit, Semnan, Iran
[3] Semnan Univ Med Sci, Dept Internal Med, Semnan, Iran
[4] Semnan Univ Med Sci, Kowsar Educ Res & Therapeut Hosp, Clin Res Dev Unit, Semnan, Iran
来源
JOURNAL OF RENAL INJURY PREVENTION | 2024年 / 13卷 / 01期
关键词
Oncohypertension; High blood pressure; Cancer; Blood pressure; Pathophysiology; Diagnosis; ANTIHYPERTENSIVE TREATMENT; PARANEOPLASTIC SYNDROMES; ONCO-HYPERTENSION; GROWTH-FACTOR; DIAGNOSIS; TARGET; RISK; PHEOCHROMOCYTOMA; CARDIOLOGY; SYSTEM;
D O I
10.34172/jrip.2024.32259
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Oncohypertension is a relatively recent concept that refers to the development of elevated blood pressure in patients with cancer, which is driven by the tumor itself. This review article aims to provide an overview of oncohypertension, including its pathophysiology, clinical implications, diagnostic approaches, and management strategies. The study discusses the association between oncological disorders and hypertension, highlighting the underlying mechanisms responsible for the development of oncohypertension. Furthermore, various diagnostic methods, including imaging techniques and laboratory tests, are discussed in detail. Finally, treatment options for oncohypertension, including both pharmacological and non -pharmacological approaches, are thoroughly reviewed to optimize blood pressure control and improve patient outcomes
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Immunoconjugates as anti-cancer agents
    Pauptit, R
    Weston, S
    Rowsell, S
    Derbyshire, D
    Tucker, A
    STRUCTURE-BASED DRUG DESIGN: EXPERIMENTAL AND COMPUTATIONAL APPROACHES, 1998, 352 : 125 - 139
  • [2] Retinoids as anti-cancer agents
    Nagpal, S
    Chandraratna, RAS
    CURRENT PHARMACEUTICAL DESIGN, 1996, 2 (03) : 295 - 316
  • [3] Anti-cancer agents - Preface
    Seymour, LK
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (25)
  • [4] Anti-cancer agents - Preface
    Niculescu-Duvaz, I
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (27)
  • [5] Indolocarbazoles as anti-cancer agents
    Prudhomme, M
    CURRENT PHARMACEUTICAL DESIGN, 1997, 3 (03) : 265 - 290
  • [6] Anti-cancer agents - Preface
    Kozikowski, AP
    Baraldi, PG
    CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (17) : U2 - U3
  • [7] Anti-cancer agents and endothelium
    Pacholczak, Renata
    Dropinski, Jerzy
    Walocha, Jerzy
    Musial, Jacek
    ONCOLOGY IN CLINICAL PRACTICE, 2018, 14 (05): : 249 - 256
  • [8] Anti-cancer agents - Preface
    Kozikowski, AP
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (12)
  • [9] Anti-cancer agents - Preface
    Capranico, G
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (22)
  • [10] Synthesis of anti-cancer agents
    Redda, Kinfe
    Gangapuram, Madhavi
    CANCER RESEARCH, 2009, 69